Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HASCOPT: Hydroxychloroquine + Azithromycin for COVID-19 in Pregnancy
NCT04365231Phase 3Withdrawn
- Sponsor
- Hôpital Saint Joseph Marseille
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Hôpital Saint Joseph Marseille. Planned start Apr 2020; status: withdrawn.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04365231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04365231.